Understanding how endocannabinoids are transported in the brain
Synaptic transport of endocannabinoids in the brain
This study is looking at how a natural substance in our bodies, called 2-AG, moves between brain cells and how this might help us find new ways to treat anxiety and depression.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project ID | NIH-10770534 on NIH RePORTER |
What this research studies
This research investigates the endocannabinoid system's role in brain function, particularly how the transport of a specific endocannabinoid, 2-arachidonoylglycerol (2-AG), occurs across synapses. By studying the mechanisms that regulate this transport, the research aims to uncover potential therapeutic targets for treating psychiatric disorders such as anxiety and depression. The approach involves examining the interactions between neurons and the factors that influence the movement of 2-AG, which is crucial for activating cannabinoid receptors and mediating behavioral effects. This could lead to new insights into how to better manage mental health conditions linked to endocannabinoid dysfunction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing anxiety, depression, or other psychiatric disorders related to endocannabinoid dysfunction.
Not a fit: Patients with conditions unrelated to the endocannabinoid system or those not experiencing psychiatric disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for mental health disorders like anxiety and depression by targeting the endocannabinoid system.
How similar studies have performed: Previous research has shown promising results in understanding the endocannabinoid system's role in mental health, suggesting that this approach could yield significant insights.
Where this research is happening
Amherst, United States
- State University of New York at Buffalo — Amherst, United States (Active)
Researchers
- Principal investigator: Haj-Dahmane, Samir — State University of New York at Buffalo
- Study coordinator: Haj-Dahmane, Samir
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.